New Zealand markets closed

Renalytix Plc (RNLX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.4253+0.0350 (+8.97%)
At close: 04:00PM EDT
0.4649 +0.04 (+9.31%)
After hours: 07:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
2,221
3,403
2,970
1,491
0
-
Cost of revenue
2,256
2,683
2,096
804
0
-
Gross profit
-35
720
874
687
0
-
Operating expenses
Research development
11,500
14,298
14,648
10,040
4,565
-
Selling general and administrative
21,759
28,662
39,524
15,436
5,750
-
Total operating expenses
33,259
42,941
54,057
33,298
10,315
-
Operating income or loss
-33,294
-42,221
-53,183
-32,611
-10,315
-
Interest expense
-
-
2
3
2
20
Total other income/expenses net
-
-
-
-
-63
-
Income before tax
-37,478
-45,605
-45,251
-35,788
-9,844
-
Income tax expense
8
2
25
-4,778
0
-
Income from continuing operations
-37,486
-45,607
-45,276
-31,010
-9,844
-
Net income
-37,486
-45,607
-45,276
-31,010
-9,844
-
Net income available to common shareholders
-37,486
-45,607
-45,276
-31,010
-9,844
-
Basic EPS
-1.00
-1.10
-1.24
-0.86
-0.34
-
Diluted EPS
-1.00
-1.10
-1.34
-0.86
-0.34
-
Basic average shares
43,600
41,105
36,431
35,742
29,540
-
Diluted average shares
43,600
41,105
36,919
35,742
29,540
-